[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Stock Sinks As Market Gains: Here's Why",
    "summary": "Amgen (AMGN) concluded the recent trading session at $258.59, signifying a -1.01% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=6385fe87a20f56dc977c5bd8c352a443c989e60fdac808ba4a344c91901a26ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736204419,
      "headline": "Amgen (AMGN) Stock Sinks As Market Gains: Here's Why",
      "id": 132294847,
      "image": "https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) concluded the recent trading session at $258.59, signifying a -1.01% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=6385fe87a20f56dc977c5bd8c352a443c989e60fdac808ba4a344c91901a26ff"
    }
  },
  {
    "ts": null,
    "headline": "Top Analyst Reports for Microsoft, Exxon Mobil & Amgen",
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and Amgen Inc. (AMGN), as well as two micro-cap stocks PrimeEnergy Resources Corporation (PNRG) and FONAR Corporation (FONR).",
    "url": "https://finnhub.io/api/news?id=25330f3372284582a64b0014220c95fa9ad2bccec8a19851f3453b2494a84ef3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736197920,
      "headline": "Top Analyst Reports for Microsoft, Exxon Mobil & Amgen",
      "id": 132292806,
      "image": "https://media.zenfs.com/en/zacks.com/d325e443265f81b37d14d0c390b4cefa",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and Amgen Inc. (AMGN), as well as two micro-cap stocks PrimeEnergy Resources Corporation (PNRG) and FONAR Corporation (FONR).",
      "url": "https://finnhub.io/api/news?id=25330f3372284582a64b0014220c95fa9ad2bccec8a19851f3453b2494a84ef3"
    }
  },
  {
    "ts": null,
    "headline": "Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?",
    "summary": "Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finnhub.io/api/news?id=ccb3ad2980d8a3d816fbabe28c93266d1edaddc91fb275ddcdff491056d83447",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736183416,
      "headline": "Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?",
      "id": 132291660,
      "image": "https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
      "url": "https://finnhub.io/api/news?id=ccb3ad2980d8a3d816fbabe28c93266d1edaddc91fb275ddcdff491056d83447"
    }
  },
  {
    "ts": null,
    "headline": "Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year",
    "summary": "Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.38 on 7th of...",
    "url": "https://finnhub.io/api/news?id=58b001d2fd13cce780b0bf67ac0837402e3b5f0f6ed6a25e88a778efa4694826",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736167917,
      "headline": "Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year",
      "id": 132291661,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.38 on 7th of...",
      "url": "https://finnhub.io/api/news?id=58b001d2fd13cce780b0bf67ac0837402e3b5f0f6ed6a25e88a778efa4694826"
    }
  },
  {
    "ts": null,
    "headline": "Amgen’s Imdylltra wins conditional MHRA licence for lung cancer",
    "summary": "Amgen’s bispecific T-cell engager (BiTE) led to an ORR of 41% in patients with extensive-stage small cell lung cancer.",
    "url": "https://finnhub.io/api/news?id=79dbaf209746b03133960cc3b88fdf3bba7179b7b3c7f33ce6e48fe48583ae43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736167424,
      "headline": "Amgen’s Imdylltra wins conditional MHRA licence for lung cancer",
      "id": 132286679,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2025/01/shutterstock_1953872293.jpg",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen’s bispecific T-cell engager (BiTE) led to an ORR of 41% in patients with extensive-stage small cell lung cancer.",
      "url": "https://finnhub.io/api/news?id=79dbaf209746b03133960cc3b88fdf3bba7179b7b3c7f33ce6e48fe48583ae43"
    }
  },
  {
    "ts": null,
    "headline": "Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade)",
    "summary": "Amgen is on pace to return to its pre-Horizon capital structure by the end of 2025. Learn why I upgrade AMGN stock from hold to buy.",
    "url": "https://finnhub.io/api/news?id=b410dbfe3eb2d686d3212cfa9a6a95ba6bef0f35e9f8733220a6c9734f3064de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736148600,
      "headline": "Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade)",
      "id": 132285461,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1412046220/image_1412046220.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen is on pace to return to its pre-Horizon capital structure by the end of 2025. Learn why I upgrade AMGN stock from hold to buy.",
      "url": "https://finnhub.io/api/news?id=b410dbfe3eb2d686d3212cfa9a6a95ba6bef0f35e9f8733220a6c9734f3064de"
    }
  },
  {
    "ts": null,
    "headline": "Amgen: Growth Potential Met By High Debt Levels",
    "summary": "Amgen's stock price remains nearly unchanged over 1.5 years, but its valuation may now be more reasonable or even a bargain. Explore more details here.",
    "url": "https://finnhub.io/api/news?id=e7f898733e64a356cc014206807e225b9e1c522dfe9973dfe3cae5913910c56f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736144723,
      "headline": "Amgen: Growth Potential Met By High Debt Levels",
      "id": 132284910,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1418324349/image_1418324349.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen's stock price remains nearly unchanged over 1.5 years, but its valuation may now be more reasonable or even a bargain. Explore more details here.",
      "url": "https://finnhub.io/api/news?id=e7f898733e64a356cc014206807e225b9e1c522dfe9973dfe3cae5913910c56f"
    }
  }
]